In a welcome move, FactSet Research Systems saw its Relative Strength Rating improve from 64 to 74 on Friday.
IBD's unique RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the best stocks often have an RS Rating of at least 80 as they begin their biggest price moves. See if FactSet Research Systems can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock manages to establish and enter a buy zone in heavy trade.
FactSet Research Systems reported 6% earnings growth last quarter, while sales growth came in at 5%.
The company earns the No. 2 rank among its peers in the Commercial Services-Market Research industry group. Moody's is the No. 1-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
